These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
189 related items for PubMed ID: 809512
1. Initiation of C3 cleavage in the alternative complement pathway. Fearon DT, Austen KF. J Immunol; 1975 Nov; 115(5):1357-61. PubMed ID: 809512 [Abstract] [Full Text] [Related]
2. Pathways of complement activation in membranoproliferative glomerulonephritis and allograft rejection. Fearon DT, Daha MR, Strom TB, Weiler JM, Carpenter CB, Austen KF. Transplant Proc; 1977 Mar; 9(1):729-39. PubMed ID: 325806 [Abstract] [Full Text] [Related]
3. Formation in the presence of C3 nephritic factor (C3NeF) of an alternative pathway C3 convertase containing uncleaved B. Daha MR, Fearon DT, Austen KF. Immunology; 1976 Nov; 31(5):789-96. PubMed ID: 992711 [Abstract] [Full Text] [Related]
4. C3 requirements for formation of alternative pathway C5 convertase. Daha MR, Fearon DT, Austen KF. J Immunol; 1976 Aug; 117(2):630-4. PubMed ID: 950465 [Abstract] [Full Text] [Related]
5. The cofactors required by C3 nephritic factor to generate a C3 convertase in vitro. Amos N, Sissons JG, Girard JF, Lachmann PJ, Peters DK. Clin Exp Immunol; 1976 Jun; 24(3):474-82. PubMed ID: 939051 [Abstract] [Full Text] [Related]
6. C3 nephritic factor (C3NeF): stabilization of fluid phase and cell-bound alternative pathway convertase. Daha MR, Fearon DT, Austen KF. J Immunol; 1976 Jan; 116(1):1-7. PubMed ID: 1245733 [Abstract] [Full Text] [Related]
7. C3b inactivator in the rheumatic diseases. Measurement by radial immunodiffusion and by inhibition of formation of properdin pathway C3 convertase. Whaley K, Schur PH, Ruddy S. J Clin Invest; 1976 Jun; 57(6):1554-63. PubMed ID: 819459 [Abstract] [Full Text] [Related]
8. Properdin: initiation of alternative complement pathway. Fearon DT, Austen KF. Proc Natl Acad Sci U S A; 1975 Aug; 72(8):3220-4. PubMed ID: 1059108 [Abstract] [Full Text] [Related]
9. Activation of the alternative complement pathway with rabbit erythrocytes by circumvention of the regulatory action of endogenous control proteins. Fearon DT, Austen KF. J Exp Med; 1977 Jul 01; 146(1):22-33. PubMed ID: 559720 [Abstract] [Full Text] [Related]
11. Eosinophil granule major basic protein regulates generation of classical and alternative-amplification pathway C3 convertases in vitro. Weiler JM, Gleich GJ. J Immunol; 1988 Mar 01; 140(5):1605-10. PubMed ID: 3346544 [Abstract] [Full Text] [Related]
12. Purification of C3b inactivator and demonstration of its two polypeptide chain structure. Fearon DT. J Immunol; 1977 Oct 01; 119(4):1248-52. PubMed ID: 894033 [Abstract] [Full Text] [Related]
14. Formation of the initial C3 convertase of the alternative complement pathway. Acquisition of C3b-like activities by spontaneous hydrolysis of the putative thioester in native C3. Pangburn MK, Schreiber RD, Müller-Eberhard HJ. J Exp Med; 1981 Sep 01; 154(3):856-67. PubMed ID: 6912277 [Abstract] [Full Text] [Related]
15. Kinetic studies on the fragmentation of the third component of complement (C3) by trypsin. Minta JO, Man D, Movat HZ. J Immunol; 1977 Jun 01; 118(6):2192-8. PubMed ID: 864257 [Abstract] [Full Text] [Related]
19. Isolation and characterization of the third component of rat complement. Daha MR, Stuffers-Heiman M, Kijlstra A, van Es LA. Immunology; 1979 Jan 01; 36(1):63-70. PubMed ID: 422228 [Abstract] [Full Text] [Related]